The medical device technology company, AppYea Inc. (APYP) closed the last session at $0.0008 after seeing a rise of 100.00% that brought its market cap to $5.31M. APYP stock traded 425.82M shares recently, greater than its average daily volume of 172.04M. In addition, the shares have been trading in a range of $0.0004 to $0.0008. The pink sheets APYP has 6.63B shares outstanding vs 6.03B float. APYP stock skyrocketed following completion of an acquisition transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free.
What APYP has gained?
AppYea is an improvement stage organization which is occupied with the obtaining, buy, support, and making of portable programming applications. It gives portable applications to iOS, Google Play, and Amazon stages. APYP’s applications incorporate Duck Quest and Ball Bearing Racer for youngsters, and Cheap RX. It additionally showcases indicative testing administrations to doctor workplaces, centers, emergency clinics, long haul care offices, medical care gatherings, and other medical services suppliers; and gives promotion administrations on the free forms of its versatile applications.
AppYea declared last week the considered culmination of its recently reported acquisition of SleepX.
- Later the acquisiiton, SleepX will keep working under its own image name as a completely claimed APYP auxiliary.
- The blended organization will zero in on additional turn of events and commercialization of SleepX’s answer, including proceeded with R&D speculations and new drives in deals and showcasing.
- Additionally, SleepX means to start an alignment preliminary with DreamIT.
- As per the market insight organization Fior Markets, the worldwide enemy of wheezing treatment market is relied upon to develop at a 9.07% CAGR to USD 8.6 billion by 2028.
- The worldwide rest apnea gadgets market is relied upon to develop at a 6.2% CAGR to USD 6.1 billion by 2028, as indicated by Grand View Research’s report.
- SleepX, presently an APYP auxiliary is a clinical gadget organization, zeroed in on the advancement of uncompetitively precise wearable checking answers for treat rest apnea and wheezing and in a general sense work on personal satisfaction.
- The organization’s answers depend on its exclusive IP arrangement of AI and detecting advances for the following, examination, and determination of crucial signs and other actual boundaries during rest time, offering outrageous precision and obstruction at reasonable expense.
- SleepX fosters a wearble innovation answer for treat wheezing and rest apnea, which is patent secured in the US, EU and Israel, and obliges two developing business sectors popular.
How this obtaining benefits APYP?
The obtaining will permit AppYea (APYP) to execute its development procedure towards the start of DreamIT’s promoting during the final part of 2022, while proceeding with its advancement with the Biomedical Department at Ben Gurion University in Israel, and sending off its first calibaration preliminary. In the interim, APYP will analyze the procurement of other synergetic exercises that will supplement the SleepX vision to further develop rest quality and personal satisfaction around the world.